3,6-Dibromo-1H-indazole(CAS: 885521-84-6)

3,6-Dibromo-1H-indazole (CAS: 885521-84-6) must comply with the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) for hazardous substances. It is also subject to the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulations in the European Union. In the United States, it falls under the purview of the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) for safety and environmental protection guidelines.

There are several alternatives to 3,6-Dibromo-1H-indazole (CAS: 885521-84-6) in synthesis, such as 1H-indazole and its brominated analogs with different substituents. Common alternative reagents include bromine and other halogenating agents like N-bromosuccinimide (NBS). These alternatives can offer similar functionalities but with varying reactivity and toxicity profiles.

The market for 3,6-Dibromo-1H-indazole (CAS: 885521-84-6) is growing due to its use in pharmaceuticals and materials science. Research trends focus on its application in drug discovery, particularly in antiviral and anticancer agents. Additionally, there is increasing interest in its use as a building block in heterocyclic synthesis and as a potential material for electronic and optoelectronic applications.

Waste containing 3,6-Dibromo-1H-indazole (CAS: 885521-84-6) should be collected in appropriate containers and stored in a cool, well-ventilated area away from incompatible substances. Proper disposal should involve incineration or professional chemical waste disposal services. Environmental protection should be ensured by following local regulations and guidelines to minimize environmental impact. Safe handling and disposal procedures should be strictly followed to prevent contamination and exposure.